Medical University of South Carolina NCORP Minority/Underserved Community Site

项目总结 南卡罗来纳医科大学/霍林斯癌症中心(MUSC/HCC)成立 作为服务不足的少数群体网站，2014年通过以下方式扩大和增强NCORP试验组合 聚集种族/民族多样化的患者和来自其他医疗服务不足群体的患者 参与NCORP研究，分享少数族裔招募和保留方面的专业知识和经验，以及 NCORP社区内的文化多样性，并有助于发展和 实施癌症关爱和癌症投放研究。在本项目期内， MUSC NCORP-MU，由两个MUSC/CC附属机构和五个社区组成 肿瘤学主要分支机构，通过以下方式为NCORP计划做出了重大贡献 不同的患者群体和领导层的有效和高效的积累已经形成了 临床试验、癌症健康差异和癌症护理服务的科学议程 研究。这些成就是通过高度投资和 由Chanita Hughes-Halbert博士(精神病学和 行为科学)，Marvella E.Ford，博士(公共卫生科学)，Carolyn D.Britten，MD (医学肿瘤学)和大卫·T·马歇尔(放射肿瘤学)医学博士，他们曾携手合作- 与MUSC/HCC的临床研究运营负责人携手建立和管理 强大的临床研究业务，为NCORP增加价值。这个领导团队也一直在努力 与其他致力于临床和癌症控制的研究人员合作，肿瘤学护理 我们集水区的提供者、癌症患者和幸存者，以促进所有类型的癌症 通过NCORP研究基地进行研究。MUSC NCORP-MU旨在改善公平 以及在种族/少数民族和其他医疗服务不足的人群中获得临床研究 以改善癌症预后，提高癌症护理服务的质量，以及 减少南卡罗来纳州和全美社区内的癌症健康差距。

PROJECT SUMMARY The Medical University of South Carolina/Hollings Cancer Center (MUSC/HCC) was established as a Minority Underserved site in 2014 to expand and enhance the NCORP trial portfolio by accruing racially/ethnically diverse patients and those from other medically underserved groups into NCORP studies, share expertise and experience on minority recruitment and retention and cultural diversity within the NCORP community, and contribute to the development and implementation of cancer care and cancer delivery research. During the current project period, the MUSC NCORP-MU, which is comprised of two MUSC/HCC sub-affiliates and five community oncology primary affiliates, has made significant contributions to the NCORP program through the effective and efficient accrual of diverse patient populations and leadership that has shaped the scientific agenda for clinical trials, cancer health disparities, and cancer care delivery research. These accomplishments were made possible through a highly invested and transdisciplinary investigative team consisting of Chanita Hughes-Halbert, PhD (Psychiatry & Behavioral Sciences), Marvella E. Ford, PhD (Public Health Sciences), Carolyn D. Britten, MD (Medical Oncology), and David T. Marshall, MD (Radiation Oncology) that has worked hand-in- hand with the clinical research operational leaders at the MUSC/HCC to establish and manage a robust clinical research operation to add value to NCORP. This leadership team has also worked collaboratively with other committed clinical and cancer control researchers, oncology care providers, cancer patients, and survivors in our catchment areas to advance all types of cancer research through the NCORP research bases. The MUSC NCORP-MU aims to improve equity and access to clinical research among racial/ethnic minorities and other medically underserved groups in order to improve cancer outcomes, enhance the quality of cancer care delivery, and reduce cancer health disparities within South Carolina and communities across the US.